Literature DB >> 19530748

The continuing unacceptable marketing of Alka-Seltzer containing aspirin for stomach-related disorders.

Francisco J de Abajo, Luis A García Rodríguez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19530748     DOI: 10.2165/00002018-200932070-00008

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  5 in total

Review 1.  Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract.

Authors:  A Lanas
Journal:  Aliment Pharmacol Ther       Date:  2004-08-01       Impact factor: 8.171

2.  Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.

Authors:  A Lanas; L A García-Rodríguez; M T Arroyo; F Gomollón; F Feu; A González-Pérez; E Zapata; G Bástida; L Rodrigo; S Santolaria; M Güell; C M de Argila; E Quintero; F Borda; J M Piqué
Journal:  Gut       Date:  2006-05-10       Impact factor: 23.059

3.  Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies.

Authors:  L A García Rodríguez; S Hernández-Díaz; F J de Abajo
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

4.  Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents.

Authors:  Joan-Ramon Laporte; Luisa Ibáñez; Xavier Vidal; Lourdes Vendrell; Roberto Leone
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications.

Authors:  Sonia Hernández-Díaz; Luis A García Rodríguez
Journal:  BMC Med       Date:  2006-09-20       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.